The Hydration Pharmaceuticals Co (ASX:HPC) Pre-Tax Income: A$-4.17 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is The Hydration Pharmaceuticals Co Pre-Tax Income?

The Hydration Pharmaceuticals Co ASX:HPC Pre-Tax Income is A$-4.17 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Pretax income is the income that a company earns before paying income taxes. The Hydration Pharmaceuticals Co's pretax income for the six months ended in Dec. 2025 was A$-2.83 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil. The Hydration Pharmaceuticals Co's pretax margin was -127.66%.

During the past 5 years, The Hydration Pharmaceuticals Co's highest Pretax Margin was -80.69%. The lowest was -177.02%. And the median was -116.57%.


The Hydration Pharmaceuticals Co  (ASX:HPC) Pre-Tax Income Explanation

The Hydration Pharmaceuticals Co's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=-2.834/2.22
=-127.66%

During the past 5 years, The Hydration Pharmaceuticals Co's highest Pretax Margin was -80.69%. The lowest was -177.02%. And the median was -116.57%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Hydration Pharmaceuticals Co Pre-Tax Income Related Terms


The Hydration Pharmaceuticals Co Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Pre-Tax Income Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Pre-Tax Income
-12.54 -15.72 -12.10 -8.96 -4.14

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -8.61 -3.13 -5.68 -1.33 -2.83

ASX:HPC vs SYY, USFD, PFGC: Pre-Tax Income Comparison

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hydration Pharmaceuticals Co Pre-Tax Income vs Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's Pre-Tax Income falls into.



The Hydration Pharmaceuticals Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

The Hydration Pharmaceuticals Co's Pretax Income for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.735+0.594+0+0+0.0010000000000003
=-4.14

The Hydration Pharmaceuticals Co's Pretax Income for the quarter that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.097+0.263+0+0+0
=-2.83

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-4.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of A$-4.17 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Pre-Tax Income of A$-4.17 Mil as of Dec. 2025. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Pre-Tax Income too high?
The Hydration Pharmaceuticals Co's current Pre-Tax Income is A$-4.17 Mil.
How does The Hydration Pharmaceuticals Co's Pre-Tax Income compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Pre-Tax Income of A$-4.17 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Retail - Defensive company?
A good Pre-Tax Income depends on the Retail - Defensive industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Pre-Tax Income is A$-4.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Pre-Tax Income of A$-4.17 Mil. The current Pre-Tax Income is A$-4.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Pre-Tax Income is A$-4.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.